These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10971406)

  • 1. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia.
    van den Oudenrijn S; Bruin M; Folman CC; Peters M; Faulkner LB; de Haas M; von dem Borne AE
    Br J Haematol; 2000 Aug; 110(2):441-8. PubMed ID: 10971406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
    Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
    Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
    Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
    Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia.
    Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K
    Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations.
    Savoia A; Dufour C; Locatelli F; Noris P; Ambaglio C; Rosti V; Zecca M; Ferrari S; di Bari F; Corcione A; Di Stazio M; Seri M; Balduini CL
    Haematologica; 2007 Sep; 92(9):1186-93. PubMed ID: 17666371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From gene to disease; from a thrombopoietin receptor gene defect to congenital amegakaryocytic thrombocytopenia].
    van den Oudenrijn S; Bruin M; de Haas M; von dem Borne AE
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):469-71. PubMed ID: 11913111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia.
    Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M
    Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease.
    Germeshausen M; Ballmaier M; Welte K
    Hum Mutat; 2006 Mar; 27(3):296. PubMed ID: 16470591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT).
    Tonelli R; Scardovi AL; Pession A; Strippoli P; Bonsi L; Vitale L; Prete A; Locatelli F; Bagnara GP; Paolucci G
    Hum Genet; 2000 Sep; 107(3):225-33. PubMed ID: 11071383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.
    Pecci A; Ragab I; Bozzi V; De Rocco D; Barozzi S; Giangregorio T; Ali H; Melazzini F; Sallam M; Alfano C; Pastore A; Balduini CL; Savoia A
    EMBO Mol Med; 2018 Jan; 10(1):63-75. PubMed ID: 29191945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic correlations.
    Steinberg O; Gilad G; Dgany O; Krasnov T; Zoldan M; Laor R; Kapelushnik J; Gabriel H; Churi C; Stein J; Yaniv I; Tamary H
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):822-5. PubMed ID: 18090929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor.
    Muraoka K; Ishii E; Ihara K; Imayoshi M; Miyazaki S; Hara T; Hamasaki Y
    Pediatr Transplant; 2005 Feb; 9(1):101-3. PubMed ID: 15667621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
    Ballmaier M; Germeshausen M; Krukemeier S; Welte K
    Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia.
    van den Oudenrijn S; Bruin M; Folman CC; Bussel J; de Haas M; von dem Borne AE
    Br J Haematol; 2002 May; 117(2):390-8. PubMed ID: 11972523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene.
    Ok Bozkaya İ; Yaralı N; Işık P; Ünsal Saç R; Tavil B; Tunç B
    Turk J Haematol; 2015 Jun; 32(2):172-4. PubMed ID: 26316487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.
    Hirata S; Takayama N; Jono-Ohnishi R; Endo H; Nakamura S; Dohda T; Nishi M; Hamazaki Y; Ishii E; Kaneko S; Otsu M; Nakauchi H; Kunishima S; Eto K
    J Clin Invest; 2013 Sep; 123(9):3802-14. PubMed ID: 23908116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia.
    Shah A; Kumar C; Shanmukhaiah C; Rajendran A; Mudaliar S; Idicula-Thomas S; Vundinti BR
    Ann Hematol; 2023 Oct; 102(10):2683-2693. PubMed ID: 37438490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia.
    Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM
    Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nonsense mutation in the MPL gene in congenital amegakaryocytic thrombocytopenia.
    Chung HS; Koh KN; Kim HJ; Kim HJ; Lee KO; Park CJ; Chi HS; Kim SH; Seo JJ; Im HJ
    Pediatr Blood Cancer; 2011 Feb; 56(2):304-6. PubMed ID: 21162090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias.
    Germeshausen M; Ballmaier M; Welte K
    Ann N Y Acad Sci; 2001 Jun; 938():305-20; discussion 320-1. PubMed ID: 11458519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.